Recent Finacing
Recent Raise
OncoOne develops multiple drug modalities targeting oxidized macrophage migration inhibitory factor (oxMIF) to treat poor-prognosis solid tumor indications.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at OncoOne.
